SlideShare a Scribd company logo
1 of 13
Download to read offline
State of the Hospital Industry
Summary and Analysis of Inflections & Themes
    Third Quarter 2010 & The Outlook

                November- 2010
Table of Contents



  Hospital Industry Themes - Third Quarter 2010 Results

  •   Volume Growth Declined Sequentially, 4Q10 Growth Will Likely Improve           Page: 2
  •   Pricing Growth Accelerated in 3Q. Managed Care Will Continue To Drive Price.   Page: 6
  •   Bad Debt Expense Is Stable. Charity Care Continues To Rise.                    Page: 7
  •   Operating Costs Are Slightly Inflationary.                                     Page: 9




                                                                                               1
Volumes Growth Declined Sequentially

Quarterly Industry Trend Summary and Analysis




                                                2
Inpatient Hospital Admissions Were Weak in 3Q
Our inpatient analysis suggests volumes contracted -2.0% in 3Q10 which is a deterioration from 2Q results of down -1.0%. The volume declines
in 3Q were a function of weak obstetric volume, declining elective cases amongst managed care patients and a difficult year-over-year flu
comparison. Moreover, managed care companies continue to aggressively push observation status for patients which is negatively impacting
inpatient volume.
Based on our research, we believe volumes improved as the quarter progressed. Specifically, July was very weak and likely tracked in the -3.0%
to -4.0% range. August appeared to have improved relative to July and September also directionally improved. We believe this improvement will
continue into 4Q and we estimate industry volume will improve from down -2.0% to a range of 0.0% to -1.0% growth in 4Q.



                                                               For Profit Hospital Industry
                                                            Organic Growth - Inpatient Volumes
                            1.0%
                                               0.4%
                            0.5%

                            0.0%
                                                               -0.2%
                           -0.5%

                           -1.0%                                                     -1.0%
                           -1.5%

                           -2.0%
                                                                                                 -2.0%
                           -2.5%
                                              4Q09A            1Q10A                2Q10A        3Q10A

                       Source: Cleveland Research Company




Source: Cleveland Research Company
                                                                                                                                                 3
Total Volumes (Inpatient & Outpatient) Were Also Weak
 Total volume or adjusted admission growth also declined sequentially. Based on our analysis, volume growth was down -0.4% in 3Q vs. being up
 0.9% in the 1st half of 2010. This is largely driven by last year’s significant flu activity in hospitals across the country coupled with weak elective
 procedure growth. Given that H1N1 pandemic quieted down near the end of October 2009 we believe volume growth will improve in 4Q as the
 year-over-year comparison gets easier.


                                                          For Profit Hospital Industry
                                                Organic Volume Growth, -Inpatient & Outpatient
                           5.0%

                           4.0%

                           3.0%
                                            2.1%
                           2.0%

                           1.0%                                   0.9%                   0.9%


                           0.0%
                                                                                                                -0.4%
                          -1.0%




                       Source: Cleveland Research Company




Source: Cleveland Research Company
                                                                                                                                                           4
Elective Procedures Remain Weak in 3Q Driven By Managed Care Patients
              We believe elective procedures continue to be weak across the sector as patients continue to defer treatment given the proliferation of high-
              deductible plans and the overall weak economic environment. We believe deferred procedures have created significant pent up demand in the
              market. While we have seen 1 large operator show flattish surgical volume as a result of elective demand coming back, we don’t believe it’s a
              widespread benefit at this point in time mainly because of high unemployment levels.

              The charts below highlight results from a large chain comparing the volume growth trends between managed care patients and non-managed care
              patients in elective and non-elective procedures. For elective procedures, managed care patients are deferring work (likely due to co-
              pays/deductibles) at a significantly greater pace than non-managed care patients (Medicare, Medicaid, uninsured, etc). The 2nd chart shows
              volume growth for non-elective procedures, which is very similar across all payers.

                           Volume Growth of Deferrable/Elective Procedures                                          Volume Growth of Non-Elective Provedures


20.0%                                                                                               0.0%
                                    16.6%
15.0%

10.0%
                                                          6.1%                     5.1%             -3.0%
 5.0%
            0.2%
 0.0%
                                                                                           -1.6%
 -5.0%
                                                                                                    -6.0%
-10.0%                                                                                                                                                  -6.3%         -6.4%
                   -9.0%                                         -8.5%
                                                                                                            -7.0%
-15.0%
                                            -14.8%
-20.0%                                                                                              -9.0%               -8.5%
         Orthopedic Surgeries      Spinal Fusions           Urology              General Medicine              OB Delivery                                     Neonatal

                                                              Non-Managed Care    Managed Care                               Non-Managed Care   Managed Care




              Source: Cleveland Research Company
                                                                                                                                                                              5
Pricing Growth Was Very Solid In 3Q10
 Total revenue growth likely trended 5% higher in 3Q which is exclusively attributable to strong pricing growth. Managed care pricing growth of
 5-7% continues to be the driver to pricing as non-commercial reimbursement continues to trend flattish. Going forward, we believe pricing growth
 could moderate in 2011 as hospitals face several reimbursement risks including weaker inpatient Medicare reimbursement beginning October 2010
 as well as Medicaid pricing risk in the 2nd half of 2011 when FMAP extension funds will be exhausted.
 Overall, we believe managed care represents ~50% of net revenues while Medicaid and Medicare represent 10% and 25% of net revenues,
 respectively. As a result, we believe pricing growth will be roughly 3-5% positive in 2011 as solid managed care pricing growth of 5-7% will
 likely offset flattish/slightly down Medicaid and flattish Medicare reimbursement. Additionally, we believe higher margin managed care volume
 will likely improve in 2011 as commercial enrollment declines should improve from down roughly -4.0% in 2010.



                                                           Hospital Industry
                                                            Pricing Growth
                               6.0%

                               5.0%                                                               4.6%
                                          3.8%
                               4.0%

                               3.0%                                             2.7%
                                                             2.2%
                               2.0%

                               1.0%

                               0.0%
                                          4Q09               1Q10              2Q10               3Q10



Source: Cleveland Research Company
                                                                                                                                                    6
Bad Debt Expense Is Stable. Charity Care Continues To Rise.


      Quarterly Industry Trend Summary and Analysis
Bad Debt Is Stable. Charity Care Continues To Rise.
Overall, bad debt expense has been contained well in a tough economic environment. The majority of operators experienced self-pay volume
declines in 3Q10. We believe this is a function of stable unemployment rates in most markets as well as a aggressive efforts to place uninsured
patients on government programs. As an example, one large chain experienced self-pay volume declines in the -5% to -10% range as Medicaid
qualifications and overall collections rose double digits.
The chart below highlights bad debt expense as a percentage of net revenues growing 0.2% which is an improvement from year-ago levels of
0.4%.
On the negative front, most hospital operators continue to see a spike in charity care as more patients are qualifying for uncompensated care and
uninsured discounts. When combining charity care, bad debt expense and uninsured discounts we believe hospitals continue to experience
unfavorable results as these categories continue to increase.


                                                                Hospital Industry
                                                        Yr/Yr Growth In Bad Debt Expense
                               0.6%
                               0.5%                              0.4%    0.4%     0.5%
                               0.4%
                               0.3%
                               0.2%                                                                     0.2%
                                                                                             0.1%
                               0.1%
                               0.0%
                              -0.1%
                              -0.2%
                              -0.3%
                                                     -0.3%
                              -0.4%
                              -0.5%      -0.4%
                                        1Q09A       2Q09A        3Q09A   4Q09A   1Q10A      2Q10A      3Q10A
                            Source: Cleveland Research Company



Source: Cleveland Research Company
                                                                                                                                                    8
Operating Costs Are Slightly Inflationary

Quarterly Industry Trend Summary and Analysis
Labor Expense Slightly Increased Sequentially
Aggressive labor expense management has been key to successfully maintaining solid operating results in a period of weak volumes for hospitals.
The most widespread tactic for cost containment continues to be flexing staff in periods of low census, which was commonly used in 3Q. We
also heard examples of facilities freezing pay and hiring activity in the interim.

Additionally, we continue to hear of restructuring efforts focused on optimizing staffing which has resulted in lower headcount at some facilities.

On a positive note, the industry has gained 38,000 employees since October 2009 according to government statistics. Moreover, the government
reported the hospital industry gained more than 5,000 employees (5%) in October vs. September 2010.

Overall, 3Q labor costs as a percentage of net revenue increased 0.6% in 3Q10 vs. a flattish result in 2Q.

                                                                 Hospital Industry
                                                           Yr/Yr Growth In Labor Costs
                                1.0%
                                                                            0.7%
                                0.8%                                                                     0.6%
                                0.6%
                                0.4%
                                                                 0.1%                    0.1%
                                0.2%
                                0.0%
                               -0.2%
                               -0.4%
                               -0.6%
                               -0.8%
                               -1.0%
                                            -0.9%
                               -1.2%



                            Source: Cleveland Research Company



Source: Cleveland Research Company
                                                                                                                                                      10
Supply Costs Continue To Be Flattish

Supply costs continue to run flattish in our index. This is likely a function of weak volume, improved GPO compliance, a lack of inflation on
medical products and successful materials management cost saving efforts.




                                                                   Hospital Industry
                                                            Yr/Yr Growth In Supply Expense
                          0.5%

                          0.3%
                                                            0.1%
                          0.1%

                                                                                                           0.0%
                         -0.1%
                                                                                         -0.2%
                         -0.3%         -0.2%                              -0.3%

                         -0.5%
                                       3Q09A                4Q09A         1Q10A          2Q10A            3Q10A
                       Source: Cleveland Research Company




Source: Cleveland Research Company
                                                                                                                                                11
Questions or Thoughts? My contact information is provided below.




 Anthony J. Deem
 Market Research Associate
 Cleveland Research Company
 Phone: (216) 649-7232
 Email: adeem@cleveland-research.com



                                                                   12

More Related Content

Similar to CRC Hospital Industry Review (3 Q10)

Vistage members outperform peers, according to Dunn & Bradstreet study
Vistage members outperform peers, according to Dunn & Bradstreet studyVistage members outperform peers, according to Dunn & Bradstreet study
Vistage members outperform peers, according to Dunn & Bradstreet studyGreg Davison
 
Vistage Brand Claim - 2010
Vistage Brand Claim - 2010Vistage Brand Claim - 2010
Vistage Brand Claim - 2010rflinn
 
Vistage Member Companies Outperform D&B
Vistage Member Companies Outperform D&BVistage Member Companies Outperform D&B
Vistage Member Companies Outperform D&Bmdschwartz777
 
Technology enabled behavior changes for diabetic patients
Technology enabled behavior changes for diabetic patientsTechnology enabled behavior changes for diabetic patients
Technology enabled behavior changes for diabetic patientsJames Rose
 
Assessing the Economics of Obesity and Obesity Interventions by Michael J. O'...
Assessing the Economics of Obesity and Obesity Interventions by Michael J. O'...Assessing the Economics of Obesity and Obesity Interventions by Michael J. O'...
Assessing the Economics of Obesity and Obesity Interventions by Michael J. O'...Wisconsin Women's Health Foundation
 
Annual State of Clinical Development Costs
Annual State of Clinical Development CostsAnnual State of Clinical Development Costs
Annual State of Clinical Development CostsTTC, llc
 
IHC -- Health reform: What it means and what's next
IHC -- Health reform: What it means and what's nextIHC -- Health reform: What it means and what's next
IHC -- Health reform: What it means and what's nextGalen Institute
 
07_Mencinger_Final
07_Mencinger_Final07_Mencinger_Final
07_Mencinger_Finalfinance42
 
In Search Of Patient Engagement Presentation For Nmh Summit Feb 2012
In Search Of Patient Engagement   Presentation For Nmh Summit Feb 2012In Search Of Patient Engagement   Presentation For Nmh Summit Feb 2012
In Search Of Patient Engagement Presentation For Nmh Summit Feb 2012James Rose
 
In Search of Patient Engagement
In Search of Patient EngagementIn Search of Patient Engagement
In Search of Patient EngagementJames Rose
 
Factors Associated with ART Non-adherence in Rural Achham, Nepal
Factors Associated with  ART Non-adherence in  Rural Achham, Nepal Factors Associated with  ART Non-adherence in  Rural Achham, Nepal
Factors Associated with ART Non-adherence in Rural Achham, Nepal Bibhusan Basnet
 
The Behavioral Health Industry From Wall Street’s Point Of View
The Behavioral Health Industry From Wall Street’s Point Of ViewThe Behavioral Health Industry From Wall Street’s Point Of View
The Behavioral Health Industry From Wall Street’s Point Of Viewanthonydeem
 
Surveillance dews Afghanistan_14_jan2013
Surveillance dews Afghanistan_14_jan2013Surveillance dews Afghanistan_14_jan2013
Surveillance dews Afghanistan_14_jan2013Islam Saeed
 
Kharfen: DC HIV Public-Private Partnerships
Kharfen: DC HIV Public-Private PartnershipsKharfen: DC HIV Public-Private Partnerships
Kharfen: DC HIV Public-Private Partnershipshealthhiv
 
RepliCel Investor/Shareholder November 2012 Presentation
RepliCel Investor/Shareholder November 2012 Presentation RepliCel Investor/Shareholder November 2012 Presentation
RepliCel Investor/Shareholder November 2012 Presentation RepliCel Life Sciences Inc.
 
Mid-Quarter Monetary Policy Review : Fullerton Securities
Mid-Quarter Monetary Policy Review : Fullerton SecuritiesMid-Quarter Monetary Policy Review : Fullerton Securities
Mid-Quarter Monetary Policy Review : Fullerton SecuritiesFullerton Securities
 

Similar to CRC Hospital Industry Review (3 Q10) (20)

Vistage members outperform peers, according to Dunn & Bradstreet study
Vistage members outperform peers, according to Dunn & Bradstreet studyVistage members outperform peers, according to Dunn & Bradstreet study
Vistage members outperform peers, according to Dunn & Bradstreet study
 
Members growth
Members growthMembers growth
Members growth
 
Vistage Brand Claim - 2010
Vistage Brand Claim - 2010Vistage Brand Claim - 2010
Vistage Brand Claim - 2010
 
Vistage Member Companies Outperform D&B
Vistage Member Companies Outperform D&BVistage Member Companies Outperform D&B
Vistage Member Companies Outperform D&B
 
Technology enabled behavior changes for diabetic patients
Technology enabled behavior changes for diabetic patientsTechnology enabled behavior changes for diabetic patients
Technology enabled behavior changes for diabetic patients
 
Assessing the Economics of Obesity and Obesity Interventions by Michael J. O'...
Assessing the Economics of Obesity and Obesity Interventions by Michael J. O'...Assessing the Economics of Obesity and Obesity Interventions by Michael J. O'...
Assessing the Economics of Obesity and Obesity Interventions by Michael J. O'...
 
Annual State of Clinical Development Costs
Annual State of Clinical Development CostsAnnual State of Clinical Development Costs
Annual State of Clinical Development Costs
 
IHC -- Health reform: What it means and what's next
IHC -- Health reform: What it means and what's nextIHC -- Health reform: What it means and what's next
IHC -- Health reform: What it means and what's next
 
S. stone e health business models for chronic conditions-experiences of basqu...
S. stone e health business models for chronic conditions-experiences of basqu...S. stone e health business models for chronic conditions-experiences of basqu...
S. stone e health business models for chronic conditions-experiences of basqu...
 
07_Mencinger_Final
07_Mencinger_Final07_Mencinger_Final
07_Mencinger_Final
 
BIG Call - April 2012
BIG Call - April 2012BIG Call - April 2012
BIG Call - April 2012
 
In Search Of Patient Engagement Presentation For Nmh Summit Feb 2012
In Search Of Patient Engagement   Presentation For Nmh Summit Feb 2012In Search Of Patient Engagement   Presentation For Nmh Summit Feb 2012
In Search Of Patient Engagement Presentation For Nmh Summit Feb 2012
 
In Search of Patient Engagement
In Search of Patient EngagementIn Search of Patient Engagement
In Search of Patient Engagement
 
Factors Associated with ART Non-adherence in Rural Achham, Nepal
Factors Associated with  ART Non-adherence in  Rural Achham, Nepal Factors Associated with  ART Non-adherence in  Rural Achham, Nepal
Factors Associated with ART Non-adherence in Rural Achham, Nepal
 
The Behavioral Health Industry From Wall Street’s Point Of View
The Behavioral Health Industry From Wall Street’s Point Of ViewThe Behavioral Health Industry From Wall Street’s Point Of View
The Behavioral Health Industry From Wall Street’s Point Of View
 
Surveillance dews Afghanistan_14_jan2013
Surveillance dews Afghanistan_14_jan2013Surveillance dews Afghanistan_14_jan2013
Surveillance dews Afghanistan_14_jan2013
 
Kharfen: DC HIV Public-Private Partnerships
Kharfen: DC HIV Public-Private PartnershipsKharfen: DC HIV Public-Private Partnerships
Kharfen: DC HIV Public-Private Partnerships
 
RepliCel Investor/Shareholder November 2012 Presentation
RepliCel Investor/Shareholder November 2012 Presentation RepliCel Investor/Shareholder November 2012 Presentation
RepliCel Investor/Shareholder November 2012 Presentation
 
Mid-Quarter Monetary Policy Review : Fullerton Securities
Mid-Quarter Monetary Policy Review : Fullerton SecuritiesMid-Quarter Monetary Policy Review : Fullerton Securities
Mid-Quarter Monetary Policy Review : Fullerton Securities
 
Danone sales q3 2012
Danone sales q3 2012  Danone sales q3 2012
Danone sales q3 2012
 

CRC Hospital Industry Review (3 Q10)

  • 1. State of the Hospital Industry Summary and Analysis of Inflections & Themes Third Quarter 2010 & The Outlook November- 2010
  • 2. Table of Contents Hospital Industry Themes - Third Quarter 2010 Results • Volume Growth Declined Sequentially, 4Q10 Growth Will Likely Improve Page: 2 • Pricing Growth Accelerated in 3Q. Managed Care Will Continue To Drive Price. Page: 6 • Bad Debt Expense Is Stable. Charity Care Continues To Rise. Page: 7 • Operating Costs Are Slightly Inflationary. Page: 9 1
  • 3. Volumes Growth Declined Sequentially Quarterly Industry Trend Summary and Analysis 2
  • 4. Inpatient Hospital Admissions Were Weak in 3Q Our inpatient analysis suggests volumes contracted -2.0% in 3Q10 which is a deterioration from 2Q results of down -1.0%. The volume declines in 3Q were a function of weak obstetric volume, declining elective cases amongst managed care patients and a difficult year-over-year flu comparison. Moreover, managed care companies continue to aggressively push observation status for patients which is negatively impacting inpatient volume. Based on our research, we believe volumes improved as the quarter progressed. Specifically, July was very weak and likely tracked in the -3.0% to -4.0% range. August appeared to have improved relative to July and September also directionally improved. We believe this improvement will continue into 4Q and we estimate industry volume will improve from down -2.0% to a range of 0.0% to -1.0% growth in 4Q. For Profit Hospital Industry Organic Growth - Inpatient Volumes 1.0% 0.4% 0.5% 0.0% -0.2% -0.5% -1.0% -1.0% -1.5% -2.0% -2.0% -2.5% 4Q09A 1Q10A 2Q10A 3Q10A Source: Cleveland Research Company Source: Cleveland Research Company 3
  • 5. Total Volumes (Inpatient & Outpatient) Were Also Weak Total volume or adjusted admission growth also declined sequentially. Based on our analysis, volume growth was down -0.4% in 3Q vs. being up 0.9% in the 1st half of 2010. This is largely driven by last year’s significant flu activity in hospitals across the country coupled with weak elective procedure growth. Given that H1N1 pandemic quieted down near the end of October 2009 we believe volume growth will improve in 4Q as the year-over-year comparison gets easier. For Profit Hospital Industry Organic Volume Growth, -Inpatient & Outpatient 5.0% 4.0% 3.0% 2.1% 2.0% 1.0% 0.9% 0.9% 0.0% -0.4% -1.0% Source: Cleveland Research Company Source: Cleveland Research Company 4
  • 6. Elective Procedures Remain Weak in 3Q Driven By Managed Care Patients We believe elective procedures continue to be weak across the sector as patients continue to defer treatment given the proliferation of high- deductible plans and the overall weak economic environment. We believe deferred procedures have created significant pent up demand in the market. While we have seen 1 large operator show flattish surgical volume as a result of elective demand coming back, we don’t believe it’s a widespread benefit at this point in time mainly because of high unemployment levels. The charts below highlight results from a large chain comparing the volume growth trends between managed care patients and non-managed care patients in elective and non-elective procedures. For elective procedures, managed care patients are deferring work (likely due to co- pays/deductibles) at a significantly greater pace than non-managed care patients (Medicare, Medicaid, uninsured, etc). The 2nd chart shows volume growth for non-elective procedures, which is very similar across all payers. Volume Growth of Deferrable/Elective Procedures Volume Growth of Non-Elective Provedures 20.0% 0.0% 16.6% 15.0% 10.0% 6.1% 5.1% -3.0% 5.0% 0.2% 0.0% -1.6% -5.0% -6.0% -10.0% -6.3% -6.4% -9.0% -8.5% -7.0% -15.0% -14.8% -20.0% -9.0% -8.5% Orthopedic Surgeries Spinal Fusions Urology General Medicine OB Delivery Neonatal Non-Managed Care Managed Care Non-Managed Care Managed Care Source: Cleveland Research Company 5
  • 7. Pricing Growth Was Very Solid In 3Q10 Total revenue growth likely trended 5% higher in 3Q which is exclusively attributable to strong pricing growth. Managed care pricing growth of 5-7% continues to be the driver to pricing as non-commercial reimbursement continues to trend flattish. Going forward, we believe pricing growth could moderate in 2011 as hospitals face several reimbursement risks including weaker inpatient Medicare reimbursement beginning October 2010 as well as Medicaid pricing risk in the 2nd half of 2011 when FMAP extension funds will be exhausted. Overall, we believe managed care represents ~50% of net revenues while Medicaid and Medicare represent 10% and 25% of net revenues, respectively. As a result, we believe pricing growth will be roughly 3-5% positive in 2011 as solid managed care pricing growth of 5-7% will likely offset flattish/slightly down Medicaid and flattish Medicare reimbursement. Additionally, we believe higher margin managed care volume will likely improve in 2011 as commercial enrollment declines should improve from down roughly -4.0% in 2010. Hospital Industry Pricing Growth 6.0% 5.0% 4.6% 3.8% 4.0% 3.0% 2.7% 2.2% 2.0% 1.0% 0.0% 4Q09 1Q10 2Q10 3Q10 Source: Cleveland Research Company 6
  • 8. Bad Debt Expense Is Stable. Charity Care Continues To Rise. Quarterly Industry Trend Summary and Analysis
  • 9. Bad Debt Is Stable. Charity Care Continues To Rise. Overall, bad debt expense has been contained well in a tough economic environment. The majority of operators experienced self-pay volume declines in 3Q10. We believe this is a function of stable unemployment rates in most markets as well as a aggressive efforts to place uninsured patients on government programs. As an example, one large chain experienced self-pay volume declines in the -5% to -10% range as Medicaid qualifications and overall collections rose double digits. The chart below highlights bad debt expense as a percentage of net revenues growing 0.2% which is an improvement from year-ago levels of 0.4%. On the negative front, most hospital operators continue to see a spike in charity care as more patients are qualifying for uncompensated care and uninsured discounts. When combining charity care, bad debt expense and uninsured discounts we believe hospitals continue to experience unfavorable results as these categories continue to increase. Hospital Industry Yr/Yr Growth In Bad Debt Expense 0.6% 0.5% 0.4% 0.4% 0.5% 0.4% 0.3% 0.2% 0.2% 0.1% 0.1% 0.0% -0.1% -0.2% -0.3% -0.3% -0.4% -0.5% -0.4% 1Q09A 2Q09A 3Q09A 4Q09A 1Q10A 2Q10A 3Q10A Source: Cleveland Research Company Source: Cleveland Research Company 8
  • 10. Operating Costs Are Slightly Inflationary Quarterly Industry Trend Summary and Analysis
  • 11. Labor Expense Slightly Increased Sequentially Aggressive labor expense management has been key to successfully maintaining solid operating results in a period of weak volumes for hospitals. The most widespread tactic for cost containment continues to be flexing staff in periods of low census, which was commonly used in 3Q. We also heard examples of facilities freezing pay and hiring activity in the interim. Additionally, we continue to hear of restructuring efforts focused on optimizing staffing which has resulted in lower headcount at some facilities. On a positive note, the industry has gained 38,000 employees since October 2009 according to government statistics. Moreover, the government reported the hospital industry gained more than 5,000 employees (5%) in October vs. September 2010. Overall, 3Q labor costs as a percentage of net revenue increased 0.6% in 3Q10 vs. a flattish result in 2Q. Hospital Industry Yr/Yr Growth In Labor Costs 1.0% 0.7% 0.8% 0.6% 0.6% 0.4% 0.1% 0.1% 0.2% 0.0% -0.2% -0.4% -0.6% -0.8% -1.0% -0.9% -1.2% Source: Cleveland Research Company Source: Cleveland Research Company 10
  • 12. Supply Costs Continue To Be Flattish Supply costs continue to run flattish in our index. This is likely a function of weak volume, improved GPO compliance, a lack of inflation on medical products and successful materials management cost saving efforts. Hospital Industry Yr/Yr Growth In Supply Expense 0.5% 0.3% 0.1% 0.1% 0.0% -0.1% -0.2% -0.3% -0.2% -0.3% -0.5% 3Q09A 4Q09A 1Q10A 2Q10A 3Q10A Source: Cleveland Research Company Source: Cleveland Research Company 11
  • 13. Questions or Thoughts? My contact information is provided below. Anthony J. Deem Market Research Associate Cleveland Research Company Phone: (216) 649-7232 Email: adeem@cleveland-research.com 12